These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24909126)

  • 21. Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms.
    Fainardi E; Castellazzi M; Tamborino C; Seraceni S; Tola MR; Granieri E; Contini C
    J Neurovirol; 2009 Sep; 15(5-6):425-33. PubMed ID: 20053141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of antibodies against myelin oligodendrocyte glycoprotein in different clinical types of multiple sclerosis.
    Zadro I; Brinar V; Horvat G; Brinar M
    Clin Neurol Neurosurg; 2007 Jan; 109(1):23-6. PubMed ID: 16750597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.
    Beltrán E; Obermeier B; Moser M; Coret F; Simó-Castelló M; Boscá I; Pérez-Miralles F; Villar LM; Senel M; Tumani H; Hohlfeld R; Casanova B; Dornmair K
    Brain; 2014 Oct; 137(Pt 10):2703-14. PubMed ID: 25060097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude.
    Lechner-Scott J; Spencer B; de Malmanche T; Attia J; Fitzgerald M; Trojano M; Grand'Maison F; Gomez JA; Izquierdo G; Duquette P; Girard M; Grammond P; Oreja-Guevara C; Hupperts R; Bergamaschi R; Boz C; Giuliani G; van Pesch V; Iuliano G; Fiol M; Cristiano E; Verheul F; Saladino ML; Slee M; Barnett M; Deri N; Flechter S; Vella N; Shaw C; Herbert J; Moore F; Petkovska-Boskova T; Jokubaitis V; Butzkueven H;
    Mult Scler; 2012 Jul; 18(7):974-82. PubMed ID: 22185806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical usefulness of oligoclonal bands].
    Falip M; Tintoré M; Jardí R; Duran I; Link H; Montalbán X
    Rev Neurol; 2001 Jun 16-30; 32(12):1120-4. PubMed ID: 11562840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.
    Anagnostouli M; Christidi F; Zalonis I; Nikolaou C; Lyrakos D; Triantafyllou N; Evdokimidis I; Kilidireas C
    Neurol Sci; 2015 Nov; 36(11):2053-60. PubMed ID: 26130146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
    Harrer A; Tumani H; Niendorf S; Lauda F; Geis C; Weishaupt A; Kleinschnitz C; Rauer S; Kuhle J; Stangel M; Weber F; Uhr M; Linnebank M; Wildemann B; Jarius S; Guger M; Ayzenberg I; Chan A; Zettl U; Wiendl H; Pilz G; Hitzl W; Weber JR; Kraus J
    Mult Scler; 2013 Aug; 19(9):1209-12. PubMed ID: 23093485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.
    Abdelhak A; Hottenrott T; Mayer C; Hintereder G; Zettl UK; Stich O; Tumani H
    PLoS One; 2017; 12(8):e0182647. PubMed ID: 28797088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
    Saadatnia M; Najafi MR; Najafi F; Davoudi V; Keyhanian K; Maghzi AH
    Neuroimmunomodulation; 2012; 19(3):195-9. PubMed ID: 22262195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MRZ reaction in primary progressive multiple sclerosis.
    Hottenrott T; Dersch R; Berger B; Rauer S; Huzly D; Stich O
    Fluids Barriers CNS; 2017 Feb; 14(1):2. PubMed ID: 28166789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
    Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
    J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.
    Stauch C; Reiber H; Rauchenzauner M; Strasak A; Pohl D; Hanefeld F; Gärtner J; Rostásy KM
    Mult Scler; 2011 Mar; 17(3):327-34. PubMed ID: 21123302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
    Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
    Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.
    Villar LM; Masjuan J; González-Porqué P; Plaza J; Sádaba MC; Roldán E; Bootello A; Alvarez-Cermeño JC
    Ann Neurol; 2003 Feb; 53(2):222-6. PubMed ID: 12557289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
    Sinclair AJ; Wienholt L; Tantsis E; Brilot F; Dale RC
    Dev Med Child Neurol; 2013 Jan; 55(1):71-5. PubMed ID: 23095051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
    Karrenbauer VD; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
    J Neuroimmunol; 2013 Jan; 254(1-2):170-3. PubMed ID: 22967351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.
    Idiman E; Ozakbas S; Dogan Y; Kosehasanogullari G
    J Neuroimmunol; 2009 Jul; 212(1-2):121-4. PubMed ID: 19457560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
    Imrell K; Greiner E; Hillert J; Masterman T
    J Neuroimmunol; 2009 May; 210(1-2):128-30. PubMed ID: 19327846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.